Candida Auris, An Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind?
Open accessThe DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
The emergence of Candida auris is considered as one of the most serious problems associated with nosocomial transmission and with infection control practices in hospital environment. This multidrug resistant species is rapidly spreading worldwide, with several described outbreaks. Until now, this species has been isolated from different hospital surfaces, where it can survive for long periods. There are multiple unanswered questions regarding C. auris, such as prevalence in population, environmental contamination, effectiveness of infection prevention and control, and impact on patient mortality. In order to understand how it spreads and discover possible reservoirs, it is essential to know the ecology, natural environment, and distribution of this species. It is also important to explore possible reasons to this recent emergence, namely the environmental presence of azoles or the possible effect of climate change on this sudden emergence. This review aims to discuss some of the most challenging issues that we need to have in mind in the management of C. auris and to raise the awareness to its presence in specific indoor environments as hospital settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Global epidemiology of Candida auris for November 2019 (image adapted from CDC [19]). Single cases were reported from Austria, Belgium, Chile, Italy, Greece, Egypt, Iran, Norway, Switzerland, Taiwan and United Arab Emirates. Multiple cases and extensive hospital transmission were reported from Australia, Bangladesh, Canada, China, Colombia, France, Germany, India, Israel, Japan, Kenya, Kuwait, Malaysia, Paskistan, Netherlands, Oman, Panama, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, UK, USA and Venezuela [20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35].](https://figures.cochat.ai/paper-figures/4489f155c1184d219817a98397ed29a5/candida-auris-an-agent-of-hospital-associated-outbreaks-which-challenging-issues-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multi-drug resistant Candida infections are on the rise due to a variety of mechanisms (Table 2), particularly C. auris, with widespread azole resistance and the potential for development of resistance to all classes of antifungals during therapy, highlighting the need for new agents to keep up with changes in epidemiology.133,145–153”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [151]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200 · cited 4×
“auris has been isolated from can help to differentiate between simple colonization and infection [89].”
BackgroundInfluentialEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 2×
“Invasive candidiasis may be caused by more than 150 Candida species [3].”
BackgroundSiegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848 · cited 1×
“Candida species are adapted to surface adherence and biofilms formation in body surfaces as well prosthetic devices, including urinary catheters and intravascular devices [72].”
BackgroundLockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662 · cited 7×
“auris isolates from the different regions (East Asia, South Asia, Africa, and South America) [11].”
BackgroundInfluentialSatoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00083.x · Cited by 1,381 · cited 1×
“auris was first described in 2009, after being isolated from the external ear canal of an inpatient in a Japanese hospital [5].”
BackgroundPappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298
Management of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,283
First hospital outbreak of the globally emerging Candida auris in a European hospital
Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall, A., Ryan, L., Shackleton, J., Trimlett, R., Meis, J. F., et al. (2016) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-016-0132-5 · Cited by 768 · cited 5×
“auris isolates from an outbreak in a cardio‐thoracic center located in the United Kingdom with other isolates from other countries in order to identify a geographic origin of the ongoing outbreak [39].”
BackgroundInfluentialChowdhary, A., Sharma, C., & Meis, J. F. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006290 · Cited by 750 · cited 3×
“Resistance is probably inducible under antifungal pressure, resulting in rapid mutational changes [64].”
BackgroundInfluential
Research works printed but not linked: 1
- Bruno, M., Jaeger, J.M., Kruppa, M.G., Zuchao, M., Ning Jiao, Y., Lowman, D.W., Giamarellos-Bourboulis, E.J., Williams, D.L., Chowdhary, A., and Meis, J.F. (July, January 30). Candida auris: Understanding the mechanisms of host immune response. Proceedings of the 20th Congress of the International Society for Human and Animal Mycology, Amsterdam, The Netherlands.
Cited by
Ahmad, S., & Alfouzan, W. (2021) · Microorganisms · doi:10.3390/microorganisms9040807 · Cited by 269
Candidemia and Invasive Candidiasis
McCarty, T. P., White, C. M., & Pappas, P. G. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.007 · Cited by 260
“12 Early identification and involvement of hospital epidemiology and infection prevention are crucial to prevent spread in a hospital environment.”
First Candida auris Outbreak during a COVID-19 Pandemic in a Tertiary-Care Center in Lebanon
Allaw, F., Kara Zahreddine, N., Ibrahim, A., Tannous, J., Taleb, H., Bizri, A. R., Dbaibo, G., & Kanj, S. S. (2021) · Pathogens · doi:10.3390/pathogens10020157 · Cited by 141
Chakrabarti, A., & Sood, P. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001318 · Cited by 133
“The antimicrobial stewardship team also plays a crucial role in checking unnecessary antibiotic and antifungal use, rapid case identification, appropriate management of cases, and coordinating with the infection control team to limit transmission [110, 111].”
Ibrexafungerp: A First-in-Class Oral Triterpenoid Glucan Synthase Inhibitor
Jallow, S., & Govender, N. P. (2021) · Journal of Fungi · doi:10.3390/jof7030163 · Cited by 129
Metadata
- Authors
- Sabino, R., Veríssimo, C., Pereira, Á. A., & Antunes, F.
- Affiliations
- University of Lisbon (PT)
- Corresponding author
- Sabino, Raquel
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2020-01-28
- Volume
- 8
- Issue
- 2
- Pages
- 181
- ISSN
- 2076-2607 (ISSN-L)
- PMC
- PMC7074697
- OpenAlex
- W3003585973
- Cited by
- 133
- References
- 106
- Citations by year
- 2026: 10 · 2025: 27 · 2024: 19 · 2023: 27 · 2022: 16 · 2021: 26 · 2020: 7
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Microorganisms (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Candida auris, nosocomial transmission, infection control, multidrug resistance, environmental contamination, hospital surfaces, climate change, fungal ecology, patient mortality, emerging fungal pathogens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Candida Auris, An Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind? https://app.cochat.ai/papers/10.3390/microorganisms8020181
- The paper
- Sabino, R., Veríssimo, C., Pereira, Á. A., & Antunes, F. (2020). Candida Auris, An Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind? Microorganisms. https://doi.org/10.3390/microorganisms8020181
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.